| Line Item | 2023-01-01 | Y/Y |
|---|---|---|
| Revenue | $3.27B | +92.3% |
| R&D Expense | $190.5M | +99.1% |
| SG&A Expense | $621.0M | +159.2% |
| Operating Income | $843.7M | -6.9% |
| Pre-tax Income | $735.9M | -18.3% |
| Income Tax | $187.2M | -4.5% |
| Net Income | $548.7M | -22.1% |
| EPS (Basic) | $9.66 | -42.3% |
| EPS (Diluted) | $9.56 |
| Line Item | 2023-01-01 | Y/Y |
|---|---|---|
| Cash & Equivalents | $292.9M | -63.5% |
| Short-term Investments | $52.1M | +102.7% |
| Accounts Receivable | $453.9M | +20.1% |
| Inventory | $524.1M | +163.6% |
| Current Assets | $1.58B | +9.4% |
| Total Assets | $8.86B | +264.4% |
| Current Liabilities | $1.01B | +211.3% |
| Line Item | 2023-01-01 | Y/Y |
|---|---|---|
| Operating Cash Flow | $885.3M | +9.9% |
| Capital Expenditures | $140.9M | -51.9% |
| Investing Cash Flow | -$1.64B | -414.6% |
| Financing Cash Flow | $252.0M | +245.6% |
| Free Cash Flow | $744.4M | +45.1% |
| -41.8% |
| Long-term Debt |
| $2.65B |
| — |
| Total Liabilities | $3.92B | +682.7% |
| Stockholders' Equity | $4.93B | +155.8% |